Loading company
Keep exploring
The themes Neogen is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Devices
Graded A or B and worth $2B or more: A first, then the largest.
MDTMedtronic plc$130BA+
SYKStryker Corp.$121.3BA+
EWEdwards Lifesciences Corporation$60.8BA+
GEHCGE Healthcare Technologies Inc.$37.4BA
GKOSGlaukos Corp$14.6BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher CorporationOct 21, 2026CBGraded C, now B
MCKMckesson CorporationNov 4, 2026BAGraded B, now A
CVSCVS Health CorpNov 4, 2026BAGraded B, now A- EWEdwards Lifesciences CorporationNov 4, 2026BAGraded B, now A
BIIBBiogen Inc.Oct 28, 2026BAGraded B, now A
How it makes money
- Food Safety: test kits, culture media, hygiene-monitoring products and related software for food and feed testing73%
- Animal Safety: veterinary products, pest controls, diagnostic products and animal genetics services27%
Shares of revenue are estimates for three months ended 2026-08-31, not figures from a filing.
Competes with
What it sells6
Molecular Detection System
A system that tests food and environmental samples for harmful bacteria by detecting their genetic material.
Reveal tests
Single-step tests used to check food and feed for contaminants, including allergens and natural toxins.
Petrifilm plates
Ready-to-use plates that help food makers and laboratories detect and count microorganisms.
Show 3 more
Neogen Analytics
Software that gathers food testing and sanitation results so customers can review patterns and track food safety work.
Ideal and Prima Tech veterinary instruments
Tools for giving animals injections, medicines and vaccines, as well as for animal identification and breeding procedures.
Provecta
A range of products used to control parasites in companion animals.
Who buys it4
- Food and animal-feed producers and processors buy tests and related supplies directly or through distributors.
- Food safety laboratories and government inspection agencies buy test kits, culture media and related products.
- Veterinarians, livestock producers, ranchers, animal-health retailers and distributors buy veterinary medicines, vaccines, instruments and pest-control products.
- Breed registries, researchers and livestock and companion-animal producers use animal genetics laboratory services.
What it stands on, and what could break it
What the business leans on
- 1Some Petrifilm products are still manufactured at 3M facilities while Neogen prepares to move production to its Lansing site.
- 2Products depend on purchased raw materials and components, and some testing methods use technology licensed from third parties.
- 3Sales in many markets rely on distributors, while products such as veterinary medicines and pest controls depend on government approvals and registrations.
What could go wrong
- 1Moving Petrifilm manufacturing from 3M to Neogen’s Lansing site could disrupt production or create integration and operating problems.
- 2The proposed sale of the animal genetics business depends on regulatory approvals and could be delayed or not completed.
- 3Tariffs, higher raw-material costs or supplier interruptions could raise production costs or limit product availability.
About Neogen Corp.
Neogen sells tests and supplies that help food and animal-feed producers find bacteria, toxins, allergens and other safety or quality problems. It also sells veterinary medicines, vaccines, instruments and pest-control products to animal-health buyers. Neogen provides animal genetics laboratory services and has agreed to sell that business to Zoetis; the sale is awaiting regulatory approvals.
- Head office
- Lansing, Michigan
- Founded
- 1981
- Employees
- 2,636 (May 31, 2026, high)
- Listed on
- NASDAQ
- Financial year ends
- May 31
Built from Neogen Corp.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
